Lumea’s IMS Viewer+™ Achieves CE Marking Under IVDR, Expanding Clinical Use Across Europe
recent articles
The first real job I had was delivering Chicago Tribunes, Chicago Sun-Times and Wall Street Journals to about 100 homes every morning. There were 48 Tribunes, 48 Sun-Times and 4 Wall Street Journals, give or take, week to week, depending on...
Tuesday, June 13th, Philips Digital Pathology Solutions will host two webinars for: North America: 10:00 AM - 11:00 AM EDT Register Asia & Europe: 3:00 PM - 4:00 PM SGT Register Philips IntelliSite Pathology Solution is now...
Grail’s Billion Dollar Bet for the Perfect Cancer Test
- Advocacy
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Conferences
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- General Healthcare News
- Genetics
- Histology
- Laboratory Informatics
- Laboratory Management & Operations
- Liquid Biopsy
- Medical Research
- Molecular Pathology
- Pathology News
- Science
- Tissue banking
Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain...
VisionGate, Inc. recently announced the appointment of Dr. David Wilbur as Medical Director of its Phoenix-based CLIA laboratory, VisionGate Biosignatures Laboratory (VBL). A world-renowned pathologist, Dr. Wilbur comes to VisionGate from...
XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, today announced a partnership agreement with PWNHealth LLC, a virtual care company offering safe and easy access to diagnostic...
Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...
